The value of repetitive transcranial magnetic stimulation combined with amisulpride enhancement olanzapine therapy for resistant treatment-refractory schizophrenia

Datos Bibliográficos

ID15517907
AutoresOu Yang (0000-0002-7267-1968, Yancheng Third People's Hospital), Liyan Yu (0000-0002-1364-9410, Yancheng Third People's Hospital), Yang Li (0000-0002-2835-6661, Tongde Hospital of Zhejiang Province), Miaozhen Zhou (Yancheng Third People's Hospital), Qianying Huang (0009-0001-1588-3577, Yancheng Third People's Hospital, autor de correspondencia)
Año2026
Volumen16
Páginas1715326-1715326
Fecha de publicación2026-01-05
Open AccessSí
TipoARTICLE
RevistaFrontiers in Psychiatry (JOURNAL)
Identificadores de la revistaISSN: 1664-0640 • E-ISSN: 1664-0640
EditorialFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2025.1715326
PMID41562002
OpenAlexW7118190523
IdiomaEN
Referencias citadas27

rTMS is a widely used treatment method for schizophrenia. This study found that rTMS combined with amisulpride enhanced olanzapine treatment for TRS can significantly improve patients' symptoms, cognitive function, and quality of life, with tolerability and safety

Amisulpride · Brain stimulation · Deep transcranial magnetic stimulation · Dopamine antagonist · Olanzapine · Schizophrenia (object-oriented programming · Tolerability · Transcranial magnetic stimulation · Electromagnetic Fields and Biological Effects · Spatial Neglect and Hemispheric Dysfunction · Transcranial Magnetic Stimulation Studies

Herramientas

Abrir DOIOpen Access